Hospital signs first coronavirus patient on to treatment trial

PUBLISHED: 13:46 03 April 2020 | UPDATED: 15:43 03 April 2020

The research and development team at QEH. Picture: QEH

The research and development team at QEH. Picture: QEH


A second Norfolk hospital has begun enrolling patients onto a research trial looking into potential treatments against coronavirus.

Dr Mohamed Elsaadany recruited the first patient at the Queen Elizabeth Hospital. Picture: QEHDr Mohamed Elsaadany recruited the first patient at the Queen Elizabeth Hospital. Picture: QEH

The Queen Elizabeth Hospital in King’s Lynn announced it has signed up its first patient, who is currently receiving treatment for the virus, to the RECOVERY trial.

The Norfolk and Norwich Hospital announced on Thursday it was also supporting the trial, which is being led by researchers in Oxford.

So far at the QEH, 71 patients have tested positive for COVID-19, 15 of these have been discharged and 12 patients have confirmed to have died.

Read more: Norfolk patients begin enrolling on coronavirus treatment trials

Dr Antonia Hardcastle, research lead at the QEH, said: “This is a really important trial, and I am glad we are in the position to offer these novel therapies to our patients in West Norfolk.”

RECOVERY is one of a growing number of trials being set up with the support of the National Institute for Health Research to help find treatments for COVID-19.

Read more: Six more coronavirus deaths in Norfolk as UK reaches new record for testing

The RECOVERY trial will look at treating patients with hydroxychloroquine, a malaria drug, or lopinavir/ritonavir, which is normally used to treat HIV, or the steroid dexamethasone, which is used in a wide range of conditions to reduce inflammation. The research study is open to all adults who are hospitalised with confirmed COVID-19.

Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness. However, older people, and those with underlying medical conditions are more likely to develop serious illness as a result of the virus, which has no specific vaccines or treatments.

Zoe Coton, Research Nurse, said: “On behalf of the team, we would like to thank everyone for their support in setting up and recruiting our first patient to this ground-breaking trial.”

Keep up to date with the latest information by joining our Norfolk Coronavirus Facebook group

If you value what this story gives you, please consider supporting the Eastern Daily Press. Click the link in the orange box above for details.

Become a supporter

This newspaper has been a central part of community life for many years. Our industry faces testing times, which is why we're asking for your support. Every contribution will help us continue to produce local journalism that makes a measurable difference to our community.

Comments have been disabled on this article.

Latest from the Eastern Daily Press